Ok, So in my typical review of the CC, I thought it was good. Again, review what has been going on with the company over the last two years and what they have accomplished. Are we all rich beyond our dreams? Doing pretty good I would say for those who have been around for a while. They are doing things right. Very calculated. A lot going on in many fronts. The call was detailed and did not sound as if Gerald was trying to cover anything up that was not already discussed in the past. They continue to learn from past mistakes/blunders (which aren't many) and are on a path to make AMBS a world class company. Think of the amount of directions and opportunities that exist. If any one of them comes to fruition, we will be fine. Based on how careful they are being bringing Lympro to market, I would say we are in good hands. To those who are unhappy with the direction AMBS is going, I say, "please enlighten us". What are we missing? All the people that surround this company, the research that is being done on MANF independent of AMBS, a blood test that makes economical sense for major pharma, ELTZ for Parkinsons, etc etc etc. Just sayin! The PPS is going to do what its going to do, especially down here in OTC land. Stop looking every minute and realize and remember why you invested in the first place. Heck, when I got here all we had was MANF. That was enough for me at the time. Gerald is not here to mislead investors for his own greed as some might suggest on other boards, They have a vision and are working hard to make it a reality. I have to respect that. Thats what makes me a shareholder. 2.7 million strong for over two years and I still sleep fine. Nothing has changed from the last quarter or even last quarter last year in terms of execution. The fact that R&D expense increased is a positive. I would have been worried had it gone down. Then I would be wondering what they are doing with their time. Ok, so thats my two cents for the quarterly CC. Just thought I would share my thoughts. Peace!